Roche reportedly nears $5 billion deal with biotech company Spark Thereapeutics

Swiss drugmaker Roche Holding AG is nearing a deal to acquire U.S. biotechnology company Spark Therapeutics Inc, the Wall Street Journal reported on Saturday, citing people familiar with the matter.

from Deals and IPOs https://ift.tt/2II8Q4W